Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · ARTELO BIOSCIENCES, INC. (ARTL)

Artelo Biosciences: Nasdaq $5M market value rule delayed by temporary stay

Neutral Impact 2 of 5 legal/regulatory Written later

The SEC approved a Nasdaq rule requiring listed companies to maintain at least $5,000,000 in market value of listed securities, and Artelo was among about 180 Nasdaq companies initially flagged as below that threshold. The rule is now under a temporary stay, and the company does not know how long the stay will last or whether the rule will be reinstated in its current form.

Key points

  • SEC approved Nasdaq's $5M MVLS rule on July 22, 2026; a temporary stay was announced July 29, 2026.
  • On October 5, 2026, the SEC published Nasdaq's proposed change tying the rule's operative date to the end of the stay; comments are due October 29, 2026.
  • Artelo says it may consider raising capital through its at-the-market equity program or other financings if the rule applies to it, but has not committed to any course of action.

The filing

CompanyARTELO BIOSCIENCES, INC. (ARTL)
Form8-K, current report
Filed with the SECOct 9, 2026, 5:15 PM ET
Accession number0001640334-26-001665

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 09, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.